JPH0142674B2 - - Google Patents
Info
- Publication number
- JPH0142674B2 JPH0142674B2 JP58038089A JP3808983A JPH0142674B2 JP H0142674 B2 JPH0142674 B2 JP H0142674B2 JP 58038089 A JP58038089 A JP 58038089A JP 3808983 A JP3808983 A JP 3808983A JP H0142674 B2 JPH0142674 B2 JP H0142674B2
- Authority
- JP
- Japan
- Prior art keywords
- plasmid
- dna
- penicillinase
- peap2
- escherichia coli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01032—Xylan endo-1,3-beta-xylosidase (3.2.1.32), i.e. endo-1-3-beta-xylanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2477—Hemicellulases not provided in a preceding group
- C12N9/248—Xylanases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01008—Endo-1,4-beta-xylanase (3.2.1.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/02—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amides (3.5.2)
- C12Y305/02006—Beta-lactamase (3.5.2.6)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
本発明は、新規プラスミド及びその調製方法並
びに該プラスミドを含有する新規微生物に関し、
代謝産物であるペニシリナーゼの菌体外選択生産
に関与する特定の遺伝情報を担うデオキシリボ核
酸(DNA)を組み込んだ新規プラスミドと該プ
ラスミドによつて形質転換した新規微生物を提供
することを目的とするものである。
プラスミドは、微生物の細胞内に見出される染
色体外遺伝子で、そのDNAの円形分子であり、
近年、微生物の遺伝子組み換えの手段として利用
され、発酵工業の分野の研究におけるその重要性
は益々増大して来ている。
近年、アミノ酸やペプチドの例にみられるよう
に、微生物の生育に必要とする特定の要求性や代
謝産物の生産能に関与する遺伝情報を担うDNA
を租み込んだプラスミドについての研究がなさ
れ、また若干のプラスミドが宿主微生物に導入さ
れ、その形質転換株が得られている。
本発明は、バチルス(Bacillus)属に属する微
生物の代謝産物であるペニシリナーゼの菌体外選
択生産に関与する遺伝情報を担うDNAを組み込
んだ新規プラスミドを調製することに成功し、更
にプラスミドをエシエリヒア・コリ
(Escherichia coli)HB101株に導入して新規且
つ有用な形質転換株、エシエリヒア・コリ
(Escherichia clli)HB101(pEAP2)を得ること
に成功して本発明を完成するに至つた。
以下、本発明について詳細に説明する。
本発明において用いられる宿主微生物は、エシ
エリヒア属のプラスミドとして知られるコリシン
E1因子等の、培養された細胞内で増殖し得る形
式をとるプラスミド(ベクターDNA)に、外来
の遺伝子DNAとしてバチルス属に属する微生物、
バチルス・No.170菌(微工研菌寄第3221号)から
調製された染色体DNA断片を組み込んだプラス
ミドを含有する、エシエリヒア・コリによつて代
表されるエシエリヒア属に属する微生物である。
前記ベクターDNAに組み込まれる、バチル
ス・No.170菌から調製された染色体DNA断片は、
前記バチルス属菌の代謝産物であるペニシリナー
ゼの菌体外選択生産に関与する遺伝情報を担う
DNAであり、前記ベクターDNAとしては、天然
に存在するものを抽出したものゝ他、増殖に必要
な部分以外のDNAの部分が一部欠落しているも
のでもよく、例えばColE1の系統、pMB9の系統、
pSC101の系統、R6Kの系統、ラムダーフアージ
の系統等が挙げられる。
また、前記ベクターDNAに前記染色体DNA断
片を組み込む方法は、既知のいずれの方法も適用
し得る。例えば、適当な制限酵素
(Endonuclease)を選択、処理してDNAを特定
部位で切断し、次いで同様に処理したベクターと
して用いるDNAと混合し、リガーゼによつて再
結合する方法が用いられる。このようにして得ら
れた前記染色体のDNA断片とベクターDNAの結
合物を、形質転換法によつて受容菌であるエシエ
リヒア属の微生物の菌体に導入し、遺伝形質とし
て安定するまで増殖すると所望の染色体上の遺伝
形質とベクターDNAの形質を併せもつ形質転換
株が得られる。
後述の実施例において得られる形質転換株は、
ベクターDNAとしてpMB9プラスミドのDNAを
用い、これにバチルス・No.170菌から調製された
染色体DNA断片を組み込んで得られた新規
pEAP2プラスミドを、エシエリヒア・コリ
HB101株(エシエリヒア・コリK−12株とエシ
エリヒア・コリB株のハイブリツド株)に導入し
て形質転換反応により得られる新規微生物であ
り、エシエリヒア・コリHB101(pEAP2)
〔Escherichia coli HB101(pEAP2)〕(微工研菌
寄第6939号(FERMP−6939)と呼称される。前
記エシエリヒア・コリHB101(pEAP2)の
pEAP2プラスミドの制限酵素切断地図は、第4
図に示すとおりである。
第4図から明らかなように、このプラスミド
は、pMB9プラスミドDNAの制限サイトのHind
サイトに前記バチルス・No.170菌のペニシリナ
ーゼの菌体外選択生産に関与する遺伝情報を担う
ペニシリナーゼDNA断片が組み込まれている
DNA円形分子、即ちpMB9プラスミドDNAと約
2000の塩基対のDNAから成る7.7KbのDNA円形
分子である。
次に、前記エシエリヒア・コリHB101
(pEAP2)の菌学的性質は、DNA受容菌である
エシエリヒア・コリHB101株の性質と、ペニシ
リン耐性を除いて、同一であるが〔Molecular
Cloning A Laboratory Manual、p.504(1982)
参照、遺伝形質:F-、hsd S 20(r B 、m B )、
rec A13、ara−14、proA2、lacY1、galK2、
rpsL20(Sm′)、xyl−5、mtl−1、supE44λ-〕、
他の特性として、前記pEAP2プラスミドの特性、
即ちペニシリナーゼ生産能の遺伝情報を担う
pEAP2プラスミドによつてペニシリナーゼを菌
体外に選択的に生産せしめる特性を附加して成る
点がその特徴である。
エシエリヒア・コリHB101(pEAP2)によるペ
ニシリナーゼの菌体外選択生産は、後述の実施例
で示されるように、菌体内生産を含めた全酵素生
産の80%以上に達し、且つ長時間その生産量が持
続される。これに対し、公知のエシエリヒア・コ
リHB101(pBR322)によるペニシリナーゼ生産
は、全酵素生産の80%以上が菌体内生産であり、
また公知のバチルス・No.170菌によるペニシリナ
ーゼの菌体外生産は長時間の持続性を欠くもので
あり、これらの点において全く対照的である。
従つて、前記エシエリヒア・コリHB101
(pEAP2)は、従来皆無であつた酵素蛋白の菌体
外選択生産能を有する微生物を創製し、且つペニ
シリナーゼを極めて有利に生産し得る微生物を提
供する点において、新規性と有用性を具備するも
のである。
また、その生産物質は目的とする単一の高分子
物質のみならず、複数の酵素蛋白類がそれぞれ菌
体外に著量に生産(分泌)され、併せて採取する
ことができる。即ち、エシエリヒア・コリ
HB101株の培養により、従来、菌体内にのみ検
出されていたアルカリホスフアターゼ及びβ−ガ
ラクトシダーゼ並びに約10種の蛋白質から成る蛋
白質群が、後述の実施例に記載の如く、それぞれ
菌体外に著量に分泌されることが明らかにされ
た。
これは、本発明によつて得られるpEAP2プラ
スミドに含まれる約2000の塩基対のDNAが、代
謝産物の菌体外選択生産(分泌)能を宿主に附与
していることを意味するものである。
以下に、本発明のプラスミドの調製方法と該プ
ラスミドを含有する前記形質転換株、エシエリヒ
ア・コリHB101(pEAP2)の調製方法並びに前記
形質転換株による効果として、ペニシリナーゼ等
の菌体外選択生産について、実施例により説明す
る。
実施例 1
(1) ペニシリナーゼ生産能の遺伝情報をもつ染色
体DNAの調製
ペニシリナーゼを菌体外に生成、蓄積する能
力を有する好アルカリ性のバチルス・No.170菌
(微工研菌寄第3221号)を培地〔(g/):グ
リセロール2.0、酵母エキス5.0、ポリペプトン
5.0、K2HPO41.0、MgSO4・7H2O0.2を
NaHCO310でPH9.0に調整したもの〕中、30℃
で19時間振盪培養を行ない、対数増殖後期の菌
体を集菌後、フエノール法によるDNA抽出法
によつて染色体DNAを抽出、精製し、染色体
DNA5mgを得た。
(2) 染色体DNA断片のベクターへの挿入
(1)で得た染色体DNA10μgをとり、制限エ
ンドヌクレアーゼHindを加え、37℃で5分、
10分、20分、30分、60分反応させて部分的に切
断した。一方、ベクターとして用いるテトラサ
イクリン抵抗性(Tetr)のpMB9プラスミド
DNA(Bethesda Research Laboratories社
(米国)製)をHindで完全に切断して65℃、
5分の熱処理後、前者と混合し、T4フアージ
由来のDNAリガーゼによつて10℃、24時間
DNA鎖の連結反応を行ない、65℃、5分の熱
処理後、反応液に2倍容のエタノールを加えて
染色体DNAを組み込んだプラスミドDNAを沈
澱、採取した。
(3) ペニシリナーゼの菌体外選択生産遺伝子を担
うプラスミドによる形質転換
エシエリヒア・コリK−12株とエシエリヒ
ア・コリB株のハイブリツド株であるエシエリ
ヒア・コリHB101株〔Molecular Cloning A
Laboratory Manual p.504(1982)参照〕
(遺伝形質:F-、hsd S 20(r B 、m B )、rec
A13、ara−14、pro A2、lac Y1、gal K2、
rps L20(Sm′)、xyl−5、mtl−1、sup
E44λ-)をLB培地(純水1当りトリプトン
(Difco)10g、酵母エキス5g、グルコース
1g、NaCl10gをPH7.0に調製したもの)10ml
に接種し、37℃で振盪培養を行ない、対数増殖
後期まで生育させた後に集菌した。これを氷冷
下、最終濃度で0.03M CaCl2の溶液に順次懸濁
させてコンピテントな細胞とした。この細胞懸
濁液に(2)で得たプラスミドDNAの溶解液を加
えて氷冷下で60分反応させ、42℃、1〜2分間
ヒートシヨツクを与えて前記プラスミドDNA
を細胞内に取り込ませた。次いで、この細胞懸
濁液を別途、前記LB培地に接種し、37℃、3
〜5時間振盪培養して形質転換反応を行なつた
後、集菌、洗滌して形質転換株、エシエリヒ
ア・コリHB101(pEAP2)(微工研菌寄第6939
号)を得た。
実施例 2
実施例1の(3)で得られた形質転換株、エシエリ
ヒア・コリHB101(pEAP2)(微工研菌寄第6939
号)(FERM P−6939)を、LB培地(1当り
トリプトン10g、酵母エキス5g、グルコース1
g、グリセロール2g、NaCl10g)100mlを含む
500ml容のフラスコで37℃にて振盪培養した。細
胞の生育(菌体量の測定)は、波長660nmにおけ
る吸光度(OD)を測定し、菌体外及び菌体内生
産のペニシリナーゼ活性をサージエント
(Sargent)の変法〔Sawai et al;Antimicrob.
Agents Chemother.13、910(1978)参照〕で測
定し、30℃、1分間に1マイクロモル(μmole)
のベンジルペニシリンを水解する酵素量をペニシ
リナーゼ1単位(U)とした。
前記形質転換株の菌体量は接種後、16時間で最
大に達し、第1図に示すとおり、菌体外ペニシリ
ナーゼの活性はほゞ20時間後から増大しはじめ、
28時間後に最大に達した(≒20U/ml)。
生産されたペニシリナーゼは非常に安定であ
り、第1図aに示されるように、更にそのまゝ培
養を48時間まで継続しても生産量は減少せず、全
酵素活性の80%以上に達した。これに対して、菌
体内ペニシリナーゼは、培養初期(接種後8〜20
時間)において認められたが、その生産は全酵素
活性の10%程度であり、最高で8U/mlに過ぎず、
しかもその活性は急速に減少し、48時間後では全
く認められなかつた。第1図bは、全酵素活性に
対する菌体外ペニシリナーゼと菌体内ペニシリナ
ーゼの生成の割合を示すものである。比較とし
て、DNA供与菌の前記バチルス・No.170菌(微工
研菌寄第3221号)及びDNA受容菌の公知のエシ
エリヒア・コリHB101(pBR322)株(ペニシリ
ナーゼ生産能の遺伝情報を担うpBR322プラスミ
ドを含有する菌株)〔Boyer etal;Gene、vol2、
p.95−113(1977)参照〕を、それぞれ培養してペ
ニシリナーゼ活性を測定した。
前記バチルス・No.170菌の場合は、使用培地
〔(g/):グルコース(又はグリセロール)
2.0、酵母エキス5.0、ポリペプトン5.0、
K2HPO41.0、MgSO4・7H2O0.2をNaHCO310で
PH9.0に調整したもの〕100mlを含む500ml容のフ
ラスコに接種し、37℃で振盪培養した。培養液の
菌体外ペニシリナーゼ活性を4時間毎に測定し、
接種後、12時間で活性は最高(19U/ml)に達
し、以後急速に減少して40時間では全く認められ
なかつた(第2図参照)。
一方、エシエリヒア・コリHB101(pBR322)
の場合は、前記エシエリヒア・コリHB101
(pEAP2)株の培養に用いたLB培地の100mlを
500ml容のフラスコに入れて接種し、37℃で振盪
培養した。第3図aに示されるように、接種後、
20時間で全活性の80%以上が菌体内ペニシリナー
ゼとして認められたが(最高35U/ml)、以後急
速に減少し、菌体外ペニシリナーゼ活性は10%以
下が認められるに過ぎなかつた。第3図bは、全
酵素活性に対する菌体外ペニシリナーゼと菌体内
ペニシリナーゼの生成の割合を示すものである。
なお、実施例1の形質転換株の培養液を10分
間、10000×gで超遠心してアンモニウム硫酸塩
で80%飽和溶液とした。この沈澱物を水に溶解
し、一夜、0.1M NaClを含む0.05M隣酸緩衝液
(PH7.0)で透析した。この透析物を同一の緩衝液
で平衡化したセフアデツクスG−75(Sephadex
G−75)に通じて精製ペニシリナーゼを得た。
また、前記バチルスNo.170菌(微工研菌寄第
3221号)の培養液を同様に処理して精製ペニシリ
ナーゼを得た。
両者のペニシリナーゼの同一性をみるために、
酵素活性におけるPHの影響、熱安定性、分子量等
を測定した。その結果、次のとおり両者の同一性
が確認された。
(a) 酵素の安定性は各PH値の緩衝液を用い、30
℃、45分でインキユベートした後、調べた。そ
の結果、両酵素は、いずれもPH7〜10で安定で
あり、至適PHはPH6.0〜7.0であつた。
(b) 酵素の熱安定性は、酵素を0.05M燐酸緩衝液
(PH7.0)に溶解し、その溶液を10分間、所定の
温度で熱処理し、残存活性をPH7.0で測定する
ことにより調べた。その結果、いずれの酵素も
50℃まで安定であつた。
(c) 酵素の分子量の測定は、ゲル過法で行なつ
た。両酵素の分子量はいずれも27000〜22000と
推定された。
実施例 3
前記エシエリヒア・コリHB101(pEAP2)(微
工研菌寄第6939号)(FERM P−6939)の菌体
外生産物質について、プラスミド(pEAP2)を
導入しないエシエリヒア・コリHB101株及び
pMB9プラスミドを導入したエシエリヒア・コリ
HB101株の生産物質と比較して、ペニシリナー
ゼ以外の酵素蛋白類を調べた結果を第1表に示
す。
なお、培養条件は、実施例1のLB培地で、37
℃にて20時間振盪培養し、また生産酵素蛋白の
内、アルカリホスフアターゼ及びβ−ガラクトシ
ダーゼの酵素活性は、波長420nmにおける吸光度
(OD)を測定して表わしたものであり、蛋白質
濃度は、培地1ml当りのmgとして表わし、その他
の条件は実施例1と同様である。
The present invention relates to a novel plasmid, a method for its preparation, and a novel microorganism containing the plasmid.
The purpose of this invention is to provide a new plasmid incorporating deoxyribonucleic acid (DNA) that carries specific genetic information involved in the extracellular selective production of penicillinase, a metabolite, and a new microorganism transformed with the plasmid. It is. Plasmids are extrachromosomal genes found within the cells of microorganisms, which are circular molecules of DNA.
In recent years, it has been used as a means of genetically modifying microorganisms, and its importance in research in the field of fermentation industry has been increasing. In recent years, as seen in the examples of amino acids and peptides, DNA carries genetic information related to the specific requirements necessary for the growth of microorganisms and the ability to produce metabolites.
Research has been carried out on plasmids containing the plasmids, and some plasmids have been introduced into host microorganisms and transformed strains have been obtained. The present invention has succeeded in preparing a new plasmid that incorporates DNA carrying genetic information involved in the extracellular selective production of penicillinase, a metabolite of a microorganism belonging to the genus Bacillus, and furthermore, the plasmid has been incorporated into a DNA that carries genetic information related to the extracellular selective production of penicillinase, a metabolite of a microorganism belonging to the genus Bacillus. The present invention was completed by successfully obtaining a new and useful transformed strain, Escherichia coli HB101 (pEAP2), by introducing the transformant into Escherichia coli HB101 strain. The present invention will be explained in detail below. The host microorganism used in the present invention is colicin, which is known as a plasmid of the genus Escherichia.
A microorganism belonging to the genus Bacillus as a foreign gene DNA is added to a plasmid (vector DNA) in a format that can proliferate in cultured cells, such as factor E1 .
It is a microorganism belonging to the genus Escherichia represented by Escherichia coli, which contains a plasmid that incorporates a chromosomal DNA fragment prepared from Bacillus No. 170 (Feikoken Bacteria No. 3221). The chromosomal DNA fragment prepared from Bacillus No. 170 to be incorporated into the vector DNA is
Responsible for the genetic information involved in the extracellular selective production of penicillinase, a metabolite of Bacillus bacteria.
The vector DNA may be extracted from naturally occurring DNA, or may be one in which part of the DNA other than the part necessary for proliferation is missing, such as the ColE 1 strain, pMB9, etc. lineage of,
Examples include the pSC101 strain, the R6K strain, and the lambda phage strain. Furthermore, any known method can be applied to incorporate the chromosomal DNA fragment into the vector DNA. For example, a method is used in which a suitable restriction enzyme (Endonuclease) is selected and treated to cut DNA at a specific site, and then the DNA is mixed with similarly treated DNA to be used as a vector and religated using ligase. The conjugate of the chromosomal DNA fragment and vector DNA obtained in this way is introduced into the cells of a recipient microorganism of the genus Escherichia by a transformation method, and is grown until it becomes stable as a genetic trait. A transformed strain that has both the genetic traits on the chromosome and the traits of the vector DNA can be obtained. The transformed strain obtained in the Examples described below is
A novel vector obtained by using pMB9 plasmid DNA as vector DNA and incorporating a chromosomal DNA fragment prepared from Bacillus No. 170 into it.
pEAP2 plasmid was added to Escherichia coli
Escherichia coli HB101 (pEAP2) is a new microorganism obtained by introducing the HB101 strain (a hybrid strain of Escherichia coli K-12 and Escherichia coli B strains) into a transformation reaction.
[Escherichia coli HB101 (pEAP2)] (referred to as FERMP-6939).
The restriction enzyme cleavage map of pEAP2 plasmid is
As shown in the figure. As is clear from Figure 4, this plasmid contains the Hind site of the restriction site of pMB9 plasmid DNA.
The site contains a penicillinase DNA fragment that carries the genetic information involved in the extracellular selective production of penicillinase from Bacillus No. 170.
DNA circular molecule, i.e. pMB9 plasmid DNA and approx.
It is a 7.7Kb DNA circular molecule consisting of 2000 base pairs of DNA. Next, the said Escherichia coli HB101
The mycological properties of (pEAP2) are the same as those of the DNA recipient strain Escherichia coli HB101, except for penicillin resistance [Molecular
Cloning A Laboratory Manual, p.504 (1982)
Reference, genetic traits: F - , hsd S 20 (r B , m B ),
rec A13, ara−14, proA2, lacY1, galK2,
rpsL20(Sm′), xyl-5, mtl-1, supE44λ - ],
Other properties include the properties of the pEAP2 plasmid;
In other words, it carries the genetic information for penicillinase production ability.
Its unique feature is that it has the added property of selectively producing penicillinase outside the bacterial body using the pEAP2 plasmid. As shown in the examples below, the extracellular selective production of penicillinase by Escherichia coli HB101 (pEAP2) reaches more than 80% of the total enzyme production, including intracellular production, and the production amount remains constant for a long time. sustained. In contrast, in penicillinase production by the well-known Escherichia coli HB101 (pBR322), more than 80% of the total enzyme production is intracellular production;
In addition, the known extracellular production of penicillinase by Bacillus No. 170 lacks long-term sustainability, and these points are in complete contrast. Therefore, the said Escherichia coli HB101
(pEAP2) is novel and useful in that it creates a microorganism that has the ability to selectively produce an enzyme protein extracellularly, which was previously absent, and provides a microorganism that can produce penicillinase extremely advantageously. It is something. In addition, the produced substances are not only a single target polymer substance, but also a plurality of enzyme proteins, each of which is produced (secreted) in large amounts outside the bacterial cell, and can be collected together. i.e. Escherichia coli
By culturing the HB101 strain, alkaline phosphatase, β-galactosidase, and a protein group consisting of about 10 proteins, which had been detected only inside the bacterial cells, were released outside the bacterial cells, as described in the Examples below. It was revealed that it was secreted in large amounts. This means that the approximately 2000 base pairs of DNA contained in the pEAP2 plasmid obtained by the present invention confers on the host the ability to selectively produce (secrete) metabolites outside the cell. be. Below, the method for preparing the plasmid of the present invention, the method for preparing the transformed strain containing the plasmid, Escherichia coli HB101 (pEAP2), and the effects of the transformed strain, regarding extracellular selective production of penicillinase, etc. This will be explained using an example. Example 1 (1) Preparation of chromosomal DNA with genetic information for penicillinase production ability Alkaliphilic Bacillus No. 170 that has the ability to produce and accumulate penicillinase outside the bacterial body (Feikoken Bacillus No. 3221) Medium [(g/): glycerol 2.0, yeast extract 5.0, polypeptone
5.0, K2HPO4 1.0 , MgSO4・7H2O0.2
pH adjusted to 9.0 with NaHCO 3 10], 30℃
After culturing with shaking for 19 hours and collecting bacterial cells in the late logarithmic growth stage, chromosomal DNA was extracted and purified using the phenol DNA extraction method.
5 mg of DNA was obtained. (2) Insertion of chromosomal DNA fragment into vector Take 10μg of chromosomal DNA obtained in (1), add restriction endonuclease Hind, and incubate at 37℃ for 5 minutes.
Partial cleavage was performed after reacting for 10, 20, 30, and 60 minutes. On the other hand, the tetracycline-resistant (Tet r ) pMB9 plasmid used as a vector
DNA (manufactured by Bethesda Research Laboratories (USA)) was completely cut with Hind and incubated at 65°C.
After 5 minutes of heat treatment, the mixture was mixed with the former and incubated at 10°C for 24 hours using T4 phage-derived DNA ligase.
A ligation reaction of the DNA strands was carried out, and after heat treatment at 65°C for 5 minutes, twice the volume of ethanol was added to the reaction solution to precipitate and collect plasmid DNA incorporating chromosomal DNA. (3) Transformation with a plasmid carrying a gene for extracellular selective production of penicillinase Escherichia coli HB101 strain, a hybrid strain of Escherichia coli K-12 and Escherichia coli B [Molecular Cloning A
See Laboratory Manual p.504 (1982)]
(Genetic trait: F - , hsd S 20 (r B , m B ), rec
A13, ara−14, pro A2, lac Y1, gal K2,
rps L20 (Sm′), xyl-5, mtl-1, sup
E44λ - ) in 10 ml of LB medium (10 g of tryptone (Difco), 5 g of yeast extract, 1 g of glucose, and 10 g of NaCl per pure water adjusted to pH 7.0)
The cells were inoculated, cultured with shaking at 37°C, grown to late logarithmic growth, and then harvested. This was sequentially suspended in a solution of 0.03M CaCl 2 at a final concentration under ice cooling to obtain competent cells. The plasmid DNA solution obtained in (2) was added to this cell suspension, reacted for 60 minutes on ice, and then subjected to a heat shock at 42°C for 1 to 2 minutes to extract the plasmid DNA.
was taken into cells. Next, this cell suspension was separately inoculated into the LB medium and incubated at 37°C for 3
After carrying out a transformation reaction by culturing with shaking for ~5 hours, the bacteria were harvested and washed to obtain the transformed strain, Escherichia coli HB101 (pEAP2) (Feikoken Bacteria Collection No. 6939).
No.) was obtained. Example 2 The transformed strain obtained in Example 1 (3), Escherichia coli HB101 (pEAP2)
(FERM P-6939) was mixed with LB medium (10 g of tryptone, 5 g of yeast extract, 1 g of glucose per plate).
g, glycerol 2g, NaCl 10g) 100ml
Shaking culture was carried out at 37°C in a 500 ml flask. Cell growth (measurement of bacterial mass) was determined by measuring the absorbance (OD) at a wavelength of 660 nm, and the activity of penicillinase produced outside and inside the bacterial cells was measured using a modified Sargent method [Sawai et al; Antimicrob.
Agents Chemother. 13 , 910 (1978)], 1 micromole per minute at 30°C.
The amount of enzyme that hydrolyzes benzylpenicillin was defined as 1 unit (U) of penicillinase. The amount of bacterial cells of the transformed strain reached its maximum 16 hours after inoculation, and as shown in Figure 1, the activity of extracellular penicillinase began to increase approximately 20 hours later.
The maximum was reached after 28 hours (≈20 U/ml). The produced penicillinase is very stable, and as shown in Figure 1a, the production amount does not decrease even if the culture is continued for up to 48 hours, reaching more than 80% of the total enzyme activity. did. On the other hand, intracellular penicillinase is produced during the initial stage of culture (8 to 20 days after inoculation).
However, its production was only about 10% of the total enzyme activity, and the maximum was only 8 U/ml.
Furthermore, the activity decreased rapidly and was not observed at all after 48 hours. FIG. 1b shows the ratio of extracellular penicillinase and intracellular penicillinase production to the total enzyme activity. For comparison, the DNA-donor Bacillus No. 170 (Feikoken Bacteria No. 3221) and the DNA-recipient strain Escherichia coli HB101 (pBR322) (pBR322 plasmid carrying the genetic information for penicillinase production ability) were used for comparison. strain) [Boyer et al; Gene, vol2,
p.95-113 (1977)] were cultured, and the penicillinase activity was measured. In the case of Bacillus No. 170, the medium used [(g/): glucose (or glycerol)
2.0, yeast extract 5.0, polypeptone 5.0,
K 2 HPO 4 1.0, MgSO 4 7H 2 O 0.2 in NaHCO 3 10
[pH adjusted to 9.0]] was inoculated into a 500 ml flask and cultured with shaking at 37°C. The extracellular penicillinase activity of the culture solution was measured every 4 hours,
The activity reached its maximum (19 U/ml) 12 hours after inoculation, and then rapidly decreased until it was no longer observed at 40 hours (see Figure 2). On the other hand, E. coli HB101 (pBR322)
In the case of Escherichia coli HB101
(pEAP2) strain 100ml of LB medium used to culture
It was placed in a 500 ml flask, inoculated, and cultured with shaking at 37°C. As shown in Figure 3a, after inoculation,
At 20 hours, more than 80% of the total activity was observed as intracellular penicillinase (maximum 35 U/ml), but it rapidly decreased thereafter, and only 10% or less of extracellular penicillinase activity was observed. FIG. 3b shows the ratio of production of extracellular penicillinase and intracellular penicillinase to the total enzyme activity. The culture solution of the transformed strain of Example 1 was ultracentrifuged at 10,000 xg for 10 minutes to make an 80% saturated solution with ammonium sulfate. This precipitate was dissolved in water and dialyzed overnight against 0.05M phosphate buffer (PH7.0) containing 0.1M NaCl. This dialysate was equilibrated with Sephadex G-75 (Sephadex G-75), which was equilibrated with the same buffer solution.
G-75) to obtain purified penicillinase. In addition, the aforementioned Bacillus No. 170 bacterium
3221) was treated in the same manner to obtain purified penicillinase. To see the identity of both penicillinase,
The influence of pH on enzyme activity, thermal stability, molecular weight, etc. were measured. As a result, the identity of the two was confirmed as follows. (a) Enzyme stability was measured at 30% by using buffer solutions with various pH values.
After incubation for 45 minutes at ℃, it was examined. As a result, both enzymes were stable at pH 7 to 10, and the optimum pH was PH 6.0 to 7.0. (b) The thermostability of the enzyme can be determined by dissolving the enzyme in 0.05M phosphate buffer (PH7.0), heat-treating the solution at a specified temperature for 10 minutes, and measuring the residual activity at pH7.0. Examined. As a result, both enzymes
It was stable up to 50℃. (c) The molecular weight of the enzyme was measured by gel filtration method. The molecular weights of both enzymes were estimated to be 27,000 to 22,000. Example 3 Regarding the extracellularly produced substances of Escherichia coli HB101 (pEAP2) (FERM P-6939), Escherichia coli HB101 strain without introducing the plasmid (pEAP2) and
Escherichia coli introduced with pMB9 plasmid
Table 1 shows the results of examining enzyme proteins other than penicillinase in comparison with the substances produced by strain HB101. The culture conditions were the LB medium of Example 1, 37
The enzyme activities of alkaline phosphatase and β-galactosidase were expressed by measuring the absorbance (OD) at a wavelength of 420 nm, and the protein concentration was Expressed as mg per ml of medium, other conditions were the same as in Example 1.
【表】
単位はmg/mlである。
[Table] Unit is mg/ml.
第1図は、本発明方法で用いたエシエリヒア・
コリHB101(pEAP2)によるペニシリナーゼの活
性を、第2図は、バチルス・No.170菌によるペニ
シリナーゼの活性を、第3図は、公知のエシエリ
ヒア・コリHB101(pBR322)によるペニシリナ
ーゼの活性をそれぞれ示すグラフである。第4図
は、エシエリヒア・コリHB101(pEAP2)のプラ
スミド(pEAP2)の制限酵素切断地図である。
Figure 1 shows Escherichia
Figure 2 is a graph showing the penicillinase activity by Bacillus No. 170, and Figure 3 is a graph showing the penicillinase activity by the known Escherichia coli HB101 (pBR322). It is. FIG. 4 is a restriction enzyme cleavage map of the plasmid (pEAP2) of Escherichia coli HB101 (pEAP2).
Claims (1)
与えるプラスミドであつて、その制限サイトの
Hindサイトにバチルス(Bacillus)属No.170菌
のペニシリナーゼの菌体外選択生産に関与する遺
伝情報を担うデオキシリボ核酸(DNA)断片を
組み込んだプラスミド。 2 プラスミドがpEAP2プラスミドである特許
請求の範囲第1項記載のプラスミド。 3 プラスミドのベクターがpMB9プラスミドの
DNAである特許請求の範囲第1項記載のプラス
ミド。 4 宿主がエシエリヒア(Escherichia)属に属
する微生物である特許請求の範囲第1項記載のプ
ラスミド。 5 エシエリヒア属に属する微生物がエシエリヒ
ア・コリ(Escherichia coli)である特許請求の
範囲第4項記載のプラスミド。 6 ペニシリナーゼの菌体外選択生産能を与える
バチルス(Bacillus)属No.170菌の染色体DNA断
片を制限酵素を用いて調製すること、前記染色体
DNA断片のペニシリナーゼの菌体外選択生産に
関与する遺伝情報を妨害しない制限酵素を用いて
プラスミドのベクターDNAを制限すること、制
限された前記プラスミドのベクターDNAの制限
サイトのHindサイトに前記染色体DNA断片を
組み換えること及び組換えられたプラスミドを抽
出することから成るペニシリナーゼの菌体外選択
生産に関与する遺伝情報を担うDNA断片を組み
込んだプラスミドの調製方法。 7 プラスミドがpEAP2プラスミドである特許
請求の範囲第6項記載の調製方法。 8 プラスミドのベクターとして、pMB9プラス
ミドのDNAを用いる特許請求の範囲第6項記載
のプラスミドの調製方法。 9 ペニシリナーゼの菌体外選択生産能を有する
エシエリヒア・コリHB101(pEAP2)
〔Escherichia coli HB101(pEAP2)〕。[Scope of Claims] 1. A plasmid that provides a host with the ability to selectively produce penicillinase in vitro, the restriction site of which
A plasmid that incorporates a deoxyribonucleic acid (DNA) fragment that carries genetic information involved in the extracellular selective production of penicillinase from Bacillus genus No. 170 at the Hind site. 2. The plasmid according to claim 1, wherein the plasmid is a pEAP2 plasmid. 3 The plasmid vector is pMB9 plasmid
The plasmid according to claim 1, which is DNA. 4. The plasmid according to claim 1, wherein the host is a microorganism belonging to the genus Escherichia. 5. The plasmid according to claim 4, wherein the microorganism belonging to the genus Escherichia is Escherichia coli. 6. Preparing, using a restriction enzyme, a chromosomal DNA fragment of Bacillus genus No. 170 that confers the ability to selectively produce penicillinase in vitro;
Extracellular selection of penicillinase for DNA fragments Restricting the vector DNA of the plasmid using a restriction enzyme that does not interfere with the genetic information involved in the production, and inserting the chromosomal DNA into the Hind site of the restriction site of the vector DNA of the restricted plasmid. A method for preparing a plasmid incorporating a DNA fragment carrying genetic information involved in the extracellular selective production of penicillinase, which comprises recombining the fragment and extracting the recombined plasmid. 7. The preparation method according to claim 6, wherein the plasmid is a pEAP2 plasmid. 8. The method for preparing a plasmid according to claim 6, using the DNA of the pMB9 plasmid as the plasmid vector. 9 Escherichia coli HB101 (pEAP2), which has the ability to selectively produce penicillinase in vitro
[Escherichia coli HB101 (pEAP2)].
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58038089A JPS59162886A (en) | 1983-03-08 | 1983-03-08 | Novel plasmid, its preparation and novel microorganism containing said plasmid |
| DK138984A DK138984A (en) | 1983-03-08 | 1984-02-29 | PLASMID, METHOD OF PRODUCING IT, MICROORGANISMS CONTAINING SAME AND PROCEDURE FOR CULTIVATING THE MICROORGANISM |
| FI840843A FI85721C (en) | 1983-03-08 | 1984-03-02 | FOERFARANDE FOER EXTRACELLULAER PRODUKTION AV PENICILLINAS, PLASMID ANVAEND VID FOERFARANDET OCH FOERFARANDE FOER KONSTRUKTION AV PLASMIDEN. |
| AT84102440T ATE61410T1 (en) | 1983-03-08 | 1984-03-07 | PLASMIDS, METHODS FOR THEIR PREPARATION, MICROORGANISMS CONTAINING SUCH PLASMIDS AND METHODS FOR CULTIVATION OF THE MICROORGANISMS. |
| DE8484102440T DE3484207D1 (en) | 1983-03-08 | 1984-03-07 | PLASMIDES, METHODS FOR PREPARING THEM, MICROORGANISMS CONTAINING THESE PLASMIDES, AND METHOD FOR CULTIVATING THE MICROORGANISMS. |
| EP88121510A EP0316023B1 (en) | 1983-03-08 | 1984-03-07 | Plasmids, methods for their construction, microorganisms carrying them and methods for the extracellular production of xylanase by cultivation of the microorganisms |
| AT88121510T ATE90387T1 (en) | 1983-03-08 | 1984-03-07 | PLASMIDS, PROCESSES FOR THEIR PRODUCTION, MICROORGANISMS CONTAINING THEM, AND METHODS FOR THE EXTRACELLULAR PRODUCTION OF XYLANASE BY GROWING THESE MICROORGANISMS. |
| DE88121510T DE3486163T2 (en) | 1983-03-08 | 1984-03-07 | Plasmids, processes for their preparation, microorganisms containing them and methods for extracellular production of xylanase by culturing these microorganisms. |
| EP84102440A EP0121138B1 (en) | 1983-03-08 | 1984-03-07 | Plasmids, methods for contruction of the same, microorganisms carrying the plasmids and methods for cultivation of the microorganisms |
| CA000449095A CA1226833A (en) | 1983-03-08 | 1984-03-08 | Plasmids, methods for construction of the same, microorganisms carrying the plasmids and methods for cultivation of the microorganism |
| US07/032,032 US4962055A (en) | 1983-03-08 | 1987-03-30 | Plasmid, method for construction of the same, microorganisms carrying the plasmid and method for cultivation of the microorganism |
| FI890246A FI86438C (en) | 1983-03-08 | 1989-01-17 | Plasmids Inducing Extracellular Secretion of Xylanase |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58038089A JPS59162886A (en) | 1983-03-08 | 1983-03-08 | Novel plasmid, its preparation and novel microorganism containing said plasmid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59162886A JPS59162886A (en) | 1984-09-13 |
| JPH0142674B2 true JPH0142674B2 (en) | 1989-09-13 |
Family
ID=12515745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58038089A Granted JPS59162886A (en) | 1983-03-08 | 1983-03-08 | Novel plasmid, its preparation and novel microorganism containing said plasmid |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59162886A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0817702B2 (en) * | 1984-12-28 | 1996-02-28 | 理化学研究所 | Novel plasmid, method for preparing the same, and novel microorganism containing the plasmid |
| JP2620852B2 (en) * | 1985-07-30 | 1997-06-18 | 理化学研究所 | Novel plasmid and novel microorganism transformed thereby |
-
1983
- 1983-03-08 JP JP58038089A patent/JPS59162886A/en active Granted
Non-Patent Citations (1)
| Title |
|---|
| JOURNAL OF BACTERIOLOGY * |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59162886A (en) | 1984-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN114891765B (en) | A kind of phospholipase and its application | |
| JP2520895B2 (en) | Method for producing L-glutamic acid | |
| EP0060663A2 (en) | A process for transforming certain microorganisms, vectors and their production, and a process for producing certain substances using said vectors | |
| JPH0142674B2 (en) | ||
| EP0135045A2 (en) | A novel plasmid and methods for its use | |
| JPH0355105B2 (en) | ||
| US5049501A (en) | Production method for PvuI restriction endonuclease | |
| FI85721C (en) | FOERFARANDE FOER EXTRACELLULAER PRODUKTION AV PENICILLINAS, PLASMID ANVAEND VID FOERFARANDET OCH FOERFARANDE FOER KONSTRUKTION AV PLASMIDEN. | |
| JP2620852B2 (en) | Novel plasmid and novel microorganism transformed thereby | |
| JPH07102140B2 (en) | Recombinant DNA | |
| JPH0142675B2 (en) | ||
| JPS61158790A (en) | Novel plasmid, preparation thereof and novel microorganism containing said plasmid | |
| JPH0638751A (en) | Production of n-acylneuraminic acid aldolase | |
| JP2681634B2 (en) | New bacterial strain with enhanced thermostable liquefied amylase production capacity | |
| JP2833793B2 (en) | Plasmid encoding heparinase, heparinase-producing strain carrying this plasmid, and method for producing heparinase | |
| US5246839A (en) | Secretion plasmid comprising the kilgene | |
| FI86438B (en) | Plasmids which induce extracellular secretion of xylanase, methods for production thereof, and methods for production of xylanase | |
| JPH0375153B2 (en) | ||
| JPS62275684A (en) | Recombinant vector and bacterial cell containing same | |
| JP2928265B2 (en) | DNA fragment, slightly acidic slightly cryogenic cellulase and method for producing the same | |
| JPS62259589A (en) | Beta-tyrosinase gene, prokaryotic cell transformed by said gene and production of l-dopa or l-tyrosine using said cell | |
| EP0316023A2 (en) | Plasmids, methods for their construction, microorganisms carrying them and methods for the extracellular production of xylanase by cultivation of the microorganisms | |
| JPH06102022B2 (en) | Recombinant DNA, production method thereof, and Bacillus bacterium containing the same | |
| JPS6062984A (en) | Novel coliform bacilli having heat-resistant beta-galactosidase gene and production of heat-resistant beta-galactosidase | |
| JPS62232386A (en) | Cellulase gene |